Johnson & Johnson JNJ
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
Key Insights
Johnson & Johnson (JNJ) Core Market Data and Business Metrics
Latest Closing Price
$155.36Price-Earnings Ratio
26.83Total Outstanding Shares
2.41 Billion SharesDividend
$1.24 Per Share QuarterlySIC Description
Pharmaceutical PreparationsPrimary Exchange
New York Stock ExchangeHeadquarters
One Johnson & Johnson Plz, New Brunswick, NJ, 08933
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Short Interest
Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
| Avg Daily Volume | Days to Cover | Settlement Date | Short Interest |
|---|---|---|---|
| 9,459,481 Shares | 2.63 | 3/14/2025 | 24,870,261 Shares |
| 10,191,152 Shares | 2.27 | 2/28/2025 | 23,102,773 Shares |
| 7,825,742 Shares | 2.35 | 2/14/2025 | 18,352,866 Shares |
| 10,734,241 Shares | 1.75 | 1/31/2025 | 18,762,304 Shares |
| 8,305,936 Shares | 2.07 | 1/15/2025 | 17,202,144 Shares |
| 8,167,374 Shares | 2.02 | 12/31/2024 | 16,457,492 Shares |
Cash Flow Statement
January 1, 2024 to December 29, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Investing Activities, Continuing | $-18.60 Billion |
| Net Cash Flow | $2.25 Billion |
| Net Cash Flow From Investing Activities | $-18.60 Billion |
| Net Cash Flow From Operating Activities, Continuing | $24.27 Billion |
| Net Cash Flow, Continuing | $2.54 Billion |
| Exchange Gains/Losses | $-289 Million |
Income Statement
January 1, 2024 to December 29, 2024
| Metric | Value |
|---|---|
| Other Operating Expenses | $19.95 Billion |
| Diluted Average Shares | $2.43 Billion |
| Net Income/Loss | $14.07 Billion |
| Income/Loss From Discontinued Operations Net Of Tax Gain/Loss On Disposal | $0 |
| Costs And Expenses | $72.13 Billion |
| Income Tax Expense/Benefit, Current | $4.80 Billion |
Comprehensive Income
January 1, 2024 to December 29, 2024
| Metric | Value |
|---|---|
| Other Comprehensive Income/Loss | $786 Million |
| Comprehensive Income/Loss Attributable To Parent | $14.85 Billion |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
| Comprehensive Income/Loss | $14.85 Billion |
Balance Sheet
January 1, 2024 to December 29, 2024
| Metric | Value |
|---|---|
| Current Liabilities | $50.32 Billion |
| Noncurrent Liabilities | $58.29 Billion |
| Assets | $180.10 Billion |
| Equity | $71.49 Billion |
| Intangible Assets | $37.62 Billion |
| Wages | $4.13 Billion |
Historical Dividends
Current dividend: $1.24 Per Share Quarterly
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| Jan 2, 2025 | Mar 4, 2025 | Feb 18, 2025 | $1.24 | Quarterly |
| Oct 15, 2024 | Dec 10, 2024 | Nov 26, 2024 | $1.24 | Quarterly |
| Jul 17, 2024 | Sep 10, 2024 | Aug 27, 2024 | $1.24 | Quarterly |
| Apr 16, 2024 | Jun 4, 2024 | May 21, 2024 | $1.24 | Quarterly |
| Jan 2, 2024 | Mar 5, 2024 | Feb 20, 2024 | $1.19 | Quarterly |
| Oct 19, 2023 | Dec 5, 2023 | Nov 21, 2023 | $1.19 | Quarterly |